Small molecules against RNA targets attract big backers

Nature Reviews Drug Discovery 16, 813 (2017). doi:10.1038/nrd.2017.239 Author: Asher Mullard Novartis, Merck, Pfizer and biotech entrepreneurs have started working on small-molecule drugs that act on an assortment of RNA targets, hoping to unlock once undruggable targets and new biology.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Tags: News and Analysis Source Type: research